Interleukin 17A (IL17A) Antibody

286€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Interleukin 17A (IL17A) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx131944
tested applications
WB, IHC, IF/ICC
Description
Interleukin 17A Antibody is a Mouse Monoclonal against Interleukin 17A.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Interleukin 17A (IL17A) |
Host | Mouse |
Reactivity | Rabbit |
Recommended Dilution | WB: 0.5-3 µg/ml, IHC: 5-30 µg/ml, IF/ICC: 5-30 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Monoclonal |
Conjugation | Unconjugated |
Isotype | IgG2a Kappa |
Clone ID | B656 |
Purification | Purified by Protein A and Protein G affinity chromatography. |
Size 1 | 100 µl |
Size 2 | 200 µl |
Size 3 | 1 ml |
Form | Liquid |
Tested Applications | WB, IHC, IF/ICC |
Buffer | 0.01 M PBS, pH 7.4, containing 0.02% sodium azide, 50% glycerol. |
Availability | Shipped within 5-7 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Alias | IL17,CTLA8,IL-1,ILA17,CTLA-8,IL-17A |
Background | Antibody anti-IL17A |
Status | RUO |
Note | Concentration: 1 mg/ml - |
Descripción
IL17A is a pro-inflammatory cytokine produced primarily by T-helper 17 (Th17) cells and other immune cells in response to infection and tissue damage IL17A plays a central role in innate and adaptive immunity by stimulating the production of chemokines, cytokines, and antimicrobial peptides that recruit neutrophils and enhance host defense against bacterial and fungal infections Dysregulated IL17A production is associated with autoimmune diseases such as psoriasis, rheumatoid arthritis, and inflammatory bowel disease, where it contributes to chronic inflammation and tissue damage IL17A also plays a role in cancer, where it can promote tumor growth and metastasis by inducing angiogenesis, immune suppression, and chronic inflammation IL17A-targeted therapies, including monoclonal antibodies such as secukinumab, have been developed to treat autoimmune and inflammatory conditions by neutralizing IL17A activity and reducing inflammation
Related Products

Horse Interleukin 17A (IL17A) ELISA Kit
Horse Interleukin 17A (IL17A) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Horse IL17A concentrations in serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Interleukin 17A (IL17A)
Ver Producto

Cow Interleukin 17A (IL17A) CLIA Kit
Cow Interleukin 17A (IL17A) Chemiluminescent Immunoassay (CLIA) Kit is a Sandwich Chemiluminescent Immunoassay (CLIA) Kit for use with Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
Ver Producto